Collaborators
Dr S Pavletic, Graft-versus-Host and Autoimmunity Unit, Experimental Transplantation and Immunology BranchNational Institutes of Health, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Dr R Nash, Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA, USA
Prof G L Mancardi, Department of Neurology, University of Genoa, Italy
Dr R Saccardi, Department of Hematology, Florence, Italy
Dr P Calabresi, Dr D Kerr, Johns Hopkins University, Baltimore, MD, USA
Dr Thomas Forsthuber, University of Texas at San Antonio, TX, USA
Dr R Burt, Northwestern University, Chicago, IL, USA
Guest Lectures
Therapeutic reconditioning of the immune system through hematopoietic stem cell transplantation, Institute for Neuroimmunology and Clinical Multiple Sclerosis Research (INiMS), Center for Molecular Neurobiology Hamburg, University Clinic Eppendorf, Hamburg, Germany, 2009
Immune reconstitution - resetting the immune system, Annual Congress SGAI-SSAI /Spring Meeting SGDV-SSDV (Swiss Society for Allergology and Immunology), Basel, Switzerland, 2007
Restoration of self tolerance in autoimmune disease by HSCT, European Group for Blood and Marrow Transplantation, Hamburg, Germany, 2006
Reconstitution of the immune repertoire and immune tolerance after HSCT, European Federation of Neurological Societies, Annual Meeting, Glasgow, UK, 2006
Immune reconstitution after hematopoietic stem cell transplantation, City of Hope Medical Center, International Symposium “Cellular Therapy for Treatment of Autoimmune Disease: Basic Science and Clinical Studies Meeting”, Newport Beach, CA, USA, 2005
Repairing the immune system in multiple sclerosis, University of Bristol, Bristol, 2005
The “immune resetting” hypothesis in hematopoietic stem cell transplantation as a therapy for multiple sclerosis, Thomas Jefferson University, Philadelphia, PA, USA, 2005
Experimental Immunotherapies for multiple sclerosis, University of Nottingham, Nottingham, 2005
Immune reconstitution after autologous hematopoietic stem cell transplantation for multiple sclerosis, Washington University, St Louis, Missouri, USA, 2004
Disease-modifying treatments for multiple sclerosis, Department of Pathology, Case Western Reserve University, Cleveland, OH, USA, 2003
Immunotherapies for MS: from mechanisms of action to disease pathogenesis, University of Maryland, Baltimore, Maryland, USA, 2002
Stem Cell Therapy for Tolerance and Tissue Regeneration, Cumming Foundation, Snowbird, UT, USA, 2002
T cell clonotype tracking: a highly specific window on the immune system, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States, 2001
Unraveling naïve, memory and effector T cell responses to human myelin antigens, University of Siena, Siena, Italy, 2000
In search of “the bad cells” in multiple sclerosis; dissecting the human myelin-specific T cell repertoire, The Max Planck Institute for Neurobiology, Martinsried (Munich) Germany, 2000
Analysis of T cell receptor repertoire in immune-mediated disorders of the CNS, University of Florence, Florence, Italy, 1999
The autoimmune hypothesis in multiple sclerosis: role of myelin antigen-specific T cell responses, The Mario Negri Sud Center for Pharmacological and Biomedical Research, S. Maria Imbaro, Italy, 1998